MP, D., & B, K. (2026). Biased Kappa-opioid Agonist Strategies in Pain Management: Approaches to Clinical Benefits with Reduced Adverse Effects. Drugs, 86(2), 161. https://doi.org/10.1007/s40265-025-02270-1
Chicago Style (17th ed.) CitationMP, Davis, and Kiselev B. "Biased Kappa-opioid Agonist Strategies in Pain Management: Approaches to Clinical Benefits with Reduced Adverse Effects." Drugs 86, no. 2 (2026): 161. https://doi.org/10.1007/s40265-025-02270-1.
MLA (9th ed.) CitationMP, Davis, and Kiselev B. "Biased Kappa-opioid Agonist Strategies in Pain Management: Approaches to Clinical Benefits with Reduced Adverse Effects." Drugs, vol. 86, no. 2, 2026, p. 161, https://doi.org/10.1007/s40265-025-02270-1.
Warning: These citations may not always be 100% accurate.